The safety and efficacy of sunitinib using a modified regimen (2 weeks on/1 week off) for treatment of metastatic renal cell carcinoma

The safety and efficacy of sunitinib using a modified regimen (2 weeks on/1 week off) for treatment of metastatic renal cell carcinoma

We prospectively investigated the safety and efficacy of sunitinib using a modified regimen (2 weeks on/1 week off) in 24 patients (22 males, 2 females ; age range 39-86 years, median 64 years) with metastatic renal cell carcinoma (RCC). During the observation period (3-62 weeks, median 21 weeks), t...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 60(2014), 5 vom: 01. Mai, Seite 209-14
1. Verfasser: Togo, Yoshikazu (VerfasserIn)
Weitere Verfasser: Shimatani, Kimihiro, Hanasaki, Tsuyoshi, Yo, Toeki, Nakanishi, Yukako, Nagasawa, Seiji, Hashimoto, Takahiko, Shiraishi, Yusuke, Taoka, Rikiya, Suzuki, Toru, Go, Shuken, Higuchi, Yoshihide, Kanematsu, Akihiro, Nojima, Michio, Tsuchihashi, Kazunari, Makino, Yuki, Shimizu, Yosuke, Kanamaru, Sojun, Kono, Yuka, Matsumoto, Keiyu, Utsunomiya, Noriaki, Ito, Noriyuki, Kawakita, Mutsushi, Yamamoto, Shingo
Format: Aufsatz
Sprache:Japanese
Veröffentlicht: 2014
Zugriff auf das übergeordnete Werk:Hinyokika kiyo. Acta urologica Japonica
Schlagworte:Journal Article Antineoplastic Agents Indoles Pyrroles Sunitinib V99T50803M